← Back
Data updated: Mar 10, 2026
ASSERTIO SPECLTY
Neurology
ASSERTIO SPECLTY is a specialty pharmaceutical company focused on Neurology. Key products include SYMPAZAN.
2009
Since
4
Drugs
-
Trials
3
Approved (2yr)
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
2 drugs
Pipeline Strength Pro
Loading...
Discontinued (2)
Company Info
- First Approval
- 2009-06-17
- Latest
- 2024-11-21
- Applications
- 3